M C Hogan

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Somatostatin analog therapy for severe polycystic liver disease: results after 2 years
    Marie C Hogan
    Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 27:3532-9. 2012
  2. ncbi Evaluation and management of pain in autosomal dominant polycystic kidney disease
    Marie C Hogan
    Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Adv Chronic Kidney Dis 17:e1-e16. 2010
  3. ncbi Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease
    Marie C Hogan
    Division of Nephrology and Hypertension, Department of Biomedical STatistics and Informatics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    J Am Soc Nephrol 21:1052-61. 2010
  4. ncbi Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection
    M C Hogan
    Department of Internal Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Kidney Dis 38:E22. 2001
  5. ncbi Unusual presentation of multiple myeloma with unilateral visual loss and numb chin syndrome in a young adult
    Marie C Hogan
    Internal Medicine, Division of Nephrology, Mayo Graduate School of Medicine and Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Hematol 70:55-9. 2002
  6. ncbi Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy
    U Specks
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Arthritis Rheum 44:2836-40. 2001
  7. ncbi Labile hypertension, increased metanephrines and imaging misadventures
    Vesna D Garovic
    Divisions of Hypertension and Nephrology, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 19:1004-6. 2004
  8. ncbi Rituximab therapy in idiopathic membranous nephropathy: a 2-year study
    Fernando C Fervenza
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN 55901, USA
    Clin J Am Soc Nephrol 5:2188-98. 2010
  9. ncbi Germline PKHD1 mutations are protective against colorectal cancer
    Christopher J Ward
    Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Hum Genet 129:345-9. 2011
  10. ncbi What the similarities of specific polycystic liver and kidney diseases can teach us about both
    Marie C Hogan
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn, USA
    Nephrol News Issues 22:29-31. 2008

Collaborators

Detail Information

Publications12

  1. ncbi Somatostatin analog therapy for severe polycystic liver disease: results after 2 years
    Marie C Hogan
    Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 27:3532-9. 2012
    ....
  2. ncbi Evaluation and management of pain in autosomal dominant polycystic kidney disease
    Marie C Hogan
    Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA
    Adv Chronic Kidney Dis 17:e1-e16. 2010
    ..A small fraction of patients have disabling chronic pain. In this review, we discuss the etiologies of pain in ADPKD; review how ADPKD patients should be assessed; and discuss medical, surgical, and other management options...
  3. ncbi Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease
    Marie C Hogan
    Division of Nephrology and Hypertension, Department of Biomedical STatistics and Informatics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    J Am Soc Nephrol 21:1052-61. 2010
    ..In summary, octreotide slowed the progressive increase in liver volume and total kidney volume, improved health perception among patients with PLD, and had an acceptable side effect profile...
  4. ncbi Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection
    M C Hogan
    Department of Internal Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Kidney Dis 38:E22. 2001
    ..These cases illustrate the need to investigate patients with nondiarrheal HUS for infection with Shiga toxin-producing E coli of the non-O157 strain variety...
  5. ncbi Unusual presentation of multiple myeloma with unilateral visual loss and numb chin syndrome in a young adult
    Marie C Hogan
    Internal Medicine, Division of Nephrology, Mayo Graduate School of Medicine and Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Hematol 70:55-9. 2002
    ..Multiple myeloma needs to be included in the differential diagnosis of cranial neuropathies and skull base neoplasms even in adults under 40 years of age...
  6. ncbi Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy
    U Specks
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Arthritis Rheum 44:2836-40. 2001
    ..This modality warrants closer examination in a carefully conducted clinical trial...
  7. ncbi Labile hypertension, increased metanephrines and imaging misadventures
    Vesna D Garovic
    Divisions of Hypertension and Nephrology, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 19:1004-6. 2004
  8. ncbi Rituximab therapy in idiopathic membranous nephropathy: a 2-year study
    Fernando C Fervenza
    Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN 55901, USA
    Clin J Am Soc Nephrol 5:2188-98. 2010
    ..This hypothesis was supported by previous pharmacokinetic (PK) analysis showing that RTX levels in the two-dose regimen were 50% lower compared with nonproteinuric patients, which could potentially result in undertreatment...
  9. ncbi Germline PKHD1 mutations are protective against colorectal cancer
    Christopher J Ward
    Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Hum Genet 129:345-9. 2011
    ..0002). We also show that the carriage rate for PKHD1 mutations in the European population is higher than previous accepted at 3.2% (1:31 genomes)...
  10. ncbi What the similarities of specific polycystic liver and kidney diseases can teach us about both
    Marie C Hogan
    Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn, USA
    Nephrol News Issues 22:29-31. 2008
  11. ncbi Characterization of PKD protein-positive exosome-like vesicles
    Marie C Hogan
    Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    J Am Soc Nephrol 20:278-88. 2009
    ..These data suggest that PKD proteins are shed in membrane particles in the urine, and these particles interact with primary cilia...
  12. ncbi Renal involvement in primary Sjögren's syndrome: a clinicopathologic study
    Saugar Maripuri
    Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin J Am Soc Nephrol 4:1423-31. 2009
    ..Renal pathology and clinical outcomes in patients with primary Sjögren's syndrome (pSS) who underwent kidney biopsy (KB) because of renal impairment are reported...